AR095097A1 - Compuestos de fenoxietoxi - Google Patents

Compuestos de fenoxietoxi

Info

Publication number
AR095097A1
AR095097A1 ARP140100313A ARP140100313A AR095097A1 AR 095097 A1 AR095097 A1 AR 095097A1 AR P140100313 A ARP140100313 A AR P140100313A AR P140100313 A ARP140100313 A AR P140100313A AR 095097 A1 AR095097 A1 AR 095097A1
Authority
AR
Argentina
Prior art keywords
phenoxyetoxi
compounds
refers
compound
formula
Prior art date
Application number
ARP140100313A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR095097A1 publication Critical patent/AR095097A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Abstract

La presente se refiere a un compuesto de la fórmula (1) o una sal del mismo farmacéuticamente aceptable.
ARP140100313A 2013-02-15 2014-01-30 Compuestos de fenoxietoxi AR095097A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361765057P 2013-02-15 2013-02-15

Publications (1)

Publication Number Publication Date
AR095097A1 true AR095097A1 (es) 2015-09-30

Family

ID=50102283

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100313A AR095097A1 (es) 2013-02-15 2014-01-30 Compuestos de fenoxietoxi

Country Status (4)

Country Link
US (1) US9000043B2 (es)
AR (1) AR095097A1 (es)
TW (1) TW201443004A (es)
WO (1) WO2014126746A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014366361B2 (en) 2013-12-17 2017-04-20 Eli Lilly And Company Phenoxyethyl cyclic amine derivatives and their activity as EP4 receptor modulators
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
HRP20211532T1 (hr) 2017-05-18 2022-01-07 Idorsia Pharmaceuticals Ltd N-supstituirani derivati indola
WO2018210992A1 (en) 2017-05-18 2018-11-22 Idorsia Pharmaceuticals Ltd Pyrimidine derivatives
CN110612296A (zh) 2017-05-18 2019-12-24 爱杜西亚药品有限公司 作为pge2受体调节剂的苯基衍生物
KR102626982B1 (ko) 2017-05-18 2024-01-18 이도르시아 파마슈티컬스 리미티드 Pge2 수용체 조절제로서의 피리미딘 유도체
JP7093791B2 (ja) 2017-05-18 2022-06-30 イドーシア ファーマシューティカルズ リミテッド Ｐｇｅ２レセプター調節剤としてのベンゾフラン及びベンゾチオフェン誘導体
GB201914585D0 (en) * 2019-10-09 2019-11-20 Heptares Therapeutics Ltd Prostaglandin ep4 receptor antagonist compounds
WO2022102731A1 (ja) 2020-11-13 2022-05-19 小野薬品工業株式会社 Ｅｐ４拮抗薬と免疫チェックポイント阻害物質との併用によるがん治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0414130B8 (pt) 2003-09-03 2021-05-25 Askat Inc compostos de fenilamida ou piridilamida, seu uso e composições farmacêuticas que os compreendem.
ATE435198T1 (de) 2004-05-04 2009-07-15 Raqualia Pharma Inc Orthosubstituierte aryl- oder heteroarylamidverbindungen
JP6152643B2 (ja) 2010-02-22 2017-06-28 株式会社ＡｓｋＡｔ Ｉｌ−２３媒介疾患を治療するためのｅｐ４受容体拮抗薬の使用

Also Published As

Publication number Publication date
US9000043B2 (en) 2015-04-07
WO2014126746A1 (en) 2014-08-21
US20140235718A1 (en) 2014-08-21
TW201443004A (zh) 2014-11-16

Similar Documents

Publication Publication Date Title
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
AR095097A1 (es) Compuestos de fenoxietoxi
PE20160862A1 (es) Polimorfo de los inhibidores de la syk
AR098274A1 (es) Inhibidor de grelina o-acil transferasa
AR101995A1 (es) COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6
UY35333A (es) Compuestos de azabencimidazol
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
DOP2014000250A (es) Nuevos compuestos de pirazol
AR105821A1 (es) COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T
EA201690894A1 (ru) Феноксиэтилы
EA201592268A1 (ru) Дигидропиридиноновые ингибиторы mgat2
CR20150325A (es) Compuestos trcíclicos para inhibir el canal cftr
EA201591915A1 (ru) Соединения феноксиэтил дигидро-1h-изохинолина
JO3742B1 (ar) مركب بيرانو داي بيريدين
CO2019005165A2 (es) Compuesto de piridona como inhibidor de c-met
CR20140114A (es) Compuestos de benzotiazolona
AR124083A2 (es) Nuevo inhibidor de sglt1
CL2019000487A1 (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humana.
CL2017002651A1 (es) Derivados de aminohidrotiazina fusionados con tetrahidrofurano los cuales son útiles en el tratamiento de la enfermedad de alzheimer
ES2571452T3 (es) Compuesto antagonista de leucotrieno B4
AR092627A1 (es) Derivados glucopiranosidos de urea
DOP2016000062A (es) Derivados de indol-urea de glucopiranosil sustituido y su uso como inhibidores de sglt

Legal Events

Date Code Title Description
FB Suspension of granting procedure